6-shogaol was understood as a favorable target effect on TNF-α (2AZ5), NF-κβ (1SVC), BDNF(1B8M), and Nrf-2 (5FZN) signaling pathways that play a key role in 3-NPA-induced HD. Here, NFE2L2 is linked to Huntington disease.